Utter Christine Marie's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Jan 10, 2025
- Accession no.
- 0001415889-25-001295
- Filed
- Jan 10, 2025
- Trade date
- Jan 7-8, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $132.5K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Utter Christine MarieCIK 0001707685 | Officer (SVP, CHIEF ACCOUNTING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | Common Stock | SSaleDisposed | −1,291 | $45.34 | −$58,533.94 | 65,983 | Direct | |
| Jan 8, 2025 | Common Stock | SSaleDisposed | −1,662 | $44.50 | −$73,959 | 64,321 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.